Publicaciones científicas

31 Publicaciones científicas disponibles

  • Dietary intake of specific amino acids and liver status in subjects with nonalcoholic fatty liver disease: fatty liver in obesity (FLiO) study

    28 de agosto de 2020 | Revista: European Journal of Nutrition


    Cristina Galarregui  1 , Irene Cantero  1 , Bertha Araceli Marin-Alejandre  1 , J Ignacio Monreal  2   3 , Mariana Elorz  2   4 , Alberto Benito-Boillos  2   4 , José Ignacio Herrero  2   5   6 , Víctor de la O  2   7 , Miguel Ruiz-Canela  2   7   8 , Helen Hermana M Hermsdorff  9 , Josefina Bressan  9 , Josep A Tur  8   10 , J Alfredo Martínez  1   2   8 , M Angeles Zulet  11   12   13 , Itziar Abete  14   15   16


  • The Metabolic and Hepatic Impact of Two Personalized Dietary Strategies in Subjects with Obesity and Nonalcoholic Fatty Liver Disease

    22 de octubre de 2019 | Revista: Nutrients

    Marin-Alejandre BA (1), Abete I (2,3), Cantero I (4), Monreal JI (5,6), Elorz M (7,8), Herrero JI (9,10,11), Benito-Boillos A (12,13), Quiroga J (4,15,16), Martinez-Echeverria A (17,18), Uriz-Otano JI (19,20), Huarte-Muniesa MP (21,22), Tur JA (23,24), Martinez JA (25,26,27), Zulet MA (28,29,30).

    (1) Department of Nutrition, Food Sciences and Physiology and Centre for Nutrition Research, Faculty of Pharmacy and Nutrition, University of Navarra, 31008 Pamplona, Spain.
    (2) Department of Nutrition, Food Sciences and Physiology and Centre for Nutrition Research, Faculty of Pharmacy and Nutrition, University of Navarra, 31008 Pamplona, Spain.
    (3) Biomedical Research Centre Network in Physiopathology of Obesity and Nutrition (CIBERobn), Instituto de Salud Carlos III, 28029 Madrid, Spain.
    (4) Department of Nutrition, Food Sciences and Physiology and Centre for Nutrition Research, Faculty of Pharmacy and Nutrition, University of Navarra, 31008 Pamplona, Spain.
    (5) Navarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain.
    (6) Clinical Chemistry Department, Clinica Universidad de Navarra 31008, Pamplona, Spain.
    (7) Navarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain.
    (8) Department of Radiology, Clinica Universidad de Navarra, 31008 Pamplona, Spain.
    (9) Navarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain.
    (10) Liver Unit, Clinica Universidad de Navarra 31008, Pamplona, Spain.
    (11) Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), 28029 Madrid, Spain.
    (12) Navarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain.
    (13) Department of Radiology, Clinica Universidad de Navarra, 31008 Pamplona, Spain.
    (14) Navarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain.
    (15) Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), 28029 Madrid, Spain.
    (16) Department of Internal Medicine, Clinica Universidad de Navarra, 31008 Pamplona, Spain.
    (17) Navarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain.
    (18) Department of Gastroenterology, Complejo Hospitalario de Navarra, 31008 Pamplona, Spain.
    (19) Navarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain.
    (20) Department of Gastroenterology, Complejo Hospitalario de Navarra, 31008 Pamplona, Spain.
    (21) Navarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain.
    (22) Department of Gastroenterology, Complejo Hospitalario de Navarra, 31008 Pamplona, Spain.
    (23) Biomedical Research Centre Network in Physiopathology of Obesity and Nutrition (CIBERobn), Instituto de Salud Carlos III, 28029 Madrid, Spain.
    (24) Research Group on Community Nutrition and Oxidative Stress, University of Balearic Islands, 07122 Palma, Spain.
    (25) Department of Nutrition, Food Sciences and Physiology and Centre for Nutrition Research, Faculty of Pharmacy and Nutrition, University of Navarra, 31008 Pamplona, Spain.
    (26) Biomedical Research Centre Network in Physiopathology of Obesity and Nutrition (CIBERobn), Instituto de Salud Carlos III, 28029 Madrid, Spain.
    (27) Navarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain.
    (28) Department of Nutrition, Food Sciences and Physiology and Centre for Nutrition Research, Faculty of Pharmacy and Nutrition, University of Navarra, 31008 Pamplona, Spain.
    (29) Biomedical Research Centre Network in Physiopathology of Obesity and Nutrition (CIBERobn), Instituto de Salud Carlos III, 28029 Madrid, Spain.
    (30) Navarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain.


  • Sex differences in ochratoxin a toxicity in F344 rats after 7 and 21 days of daily oral administration

    1 de enero de 2018 | Revista: Food Chemical Toxicology

    Pastor L (1), Vettorazzi A (2), Enciso JM (3), González-Peñas E (4), García-Jalón JA (5), Monreal JI (6), López de Cerain A (7).

    (1) University of Navarra, Department of Pharmacology and Toxicology, Faculty of Pharmacy and Nutrition, c/Irunlarrea 1, 31008, Pamplona, Spain.
    (2) University of Navarra, Department of Pharmacology and Toxicology, Faculty of Pharmacy and Nutrition, c/Irunlarrea 1, 31008, Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, Spain.
    (3) University of Navarra, Department of Pharmacology and Toxicology, Faculty of Pharmacy and Nutrition, c/Irunlarrea 1, 31008, Pamplona, Spain.
    (4) University of Navarra, Department of Organic and Pharmaceutical Chemistry, Faculty of Pharmacy and Nutrition, c/Irunlarrea 1, 31008, Pamplona, Spain.
    (5) University of Zaragoza, Department of Animal Pathology, Faculty of Veterinary, c/ Miguel Server 177, 50013 Zaragoza, Spain.
    (6) University of Navarra, Department of Clinical Chemistry, Clínica Universidad de Navarra, Pamplona, Spain.
    (7) University of Navarra, Department of Pharmacology and Toxicology, Faculty of Pharmacy and Nutrition, c/Irunlarrea 1, 31008, Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, Spain.


  • The Role and Potential Therapeutic Implications of the Fibroblast Growth Factors in Energy Balance and Type 2 Diabetes

    1 de junio de 2017 | Revista: Current Diabetes Report

    Izaguirre M (1,2), Gil MJ (3), Monreal I (3), Montecucco F (4,5), Frühbeck G (1,2,6,7), Catalán V (8,9,10).

    (1) Metabolic Research Laboratory, Clínica Universidad de Navarra, Avda. Pío XII, 36, 31008, Pamplona, Spain.
    (2) CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Pamplona, Spain.
    (3) Department of Biochemistry, Clínica Universidad de Navarra, Pamplona, Spain.
    (4) Department of Internal Medicine, University of Genoa, Genoa, Italy.
    (5) IRCCS AOU San Martino-IST, Genoa, Italy.
    (6) Obesity and Adipobiology Group, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
    (7) Department of Endocrinology & Nutrition, Clínica Universidad de Navarra, Pamplona, Spain.
    (8) Metabolic Research Laboratory, Clínica Universidad de Navarra, Avda. Pío XII, 36, 31008, Pamplona, Spain.
    (9) CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Pamplona, Spain.
    (10) Obesity and Adipobiology Group, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.

COVID-19